Nicolas Frey

1.3k total citations
48 papers, 932 citations indexed

About

Nicolas Frey is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Nicolas Frey has authored 48 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 10 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Oncology. Recurrent topics in Nicolas Frey's work include Statistical Methods in Clinical Trials (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Lung Cancer Treatments and Mutations (8 papers). Nicolas Frey is often cited by papers focused on Statistical Methods in Clinical Trials (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Lung Cancer Treatments and Mutations (8 papers). Nicolas Frey collaborates with scholars based in Switzerland, United States and United Kingdom. Nicolas Frey's co-authors include Mats O. Karlsson, Susan Grange, Hanna E. Silber, Sylvie Retout, Thasia Woodworth, Ronald Gieschke, Leonid Gibiansky, Ulrika S. H. Simonsson, Dale N. Moss and R. R. Johnson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Hepatology.

In The Last Decade

Nicolas Frey

48 papers receiving 896 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicolas Frey Switzerland	19	237	230	151	109	103	48	932
Nitin Roper United States	16	461 1.9×	78 0.3×	231 1.5×	40 0.4×	80 0.8×	44	1.2k
Jielin Sun United States	36	1.2k 5.1×	195 0.8×	181 1.2×	51 0.5×	319 3.1×	94	3.0k
Bin Yao China	16	409 1.7×	353 1.5×	243 1.6×	89 0.8×	33 0.3×	69	1.2k
Nathalie Nicolaı̈ew France	19	418 1.8×	201 0.9×	156 1.0×	18 0.2×	68 0.7×	25	1.3k
Ina Koch Germany	18	505 2.1×	126 0.5×	135 0.9×	16 0.1×	92 0.9×	33	1.6k
Sadahito Kuwao Japan	20	338 1.4×	45 0.2×	213 1.4×	44 0.4×	53 0.5×	80	1.2k
Seidu Inusah United States	11	127 0.5×	123 0.5×	124 0.8×	117 1.1×	43 0.4×	16	1.3k
Anshu Marathe United States	11	183 0.8×	53 0.2×	26 0.2×	59 0.5×	72 0.7×	22	559
Meihua Wang China	15	274 1.2×	55 0.2×	213 1.4×	29 0.3×	77 0.7×	39	1.3k
Sumit Isharwal United States	14	549 2.3×	231 1.0×	94 0.6×	31 0.3×	21 0.2×	33	1.4k

Countries citing papers authored by Nicolas Frey

Since Specialization

Citations

This map shows the geographic impact of Nicolas Frey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Frey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Frey more than expected).

Fields of papers citing papers by Nicolas Frey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Frey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Frey. The network helps show where Nicolas Frey may publish in the future.

Co-authorship network of co-authors of Nicolas Frey

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Frey. A scholar is included among the top collaborators of Nicolas Frey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Frey. Nicolas Frey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jamois, Candice, David C. Turner, Leonid Gibiansky, et al.. (2025). Tocilizumab Dosing for Management of T Cell‐Engaging Bispecific Antibody‐Related CRS in Patients With R/R B‐Cell NHL. Clinical Pharmacology & Therapeutics. 118(4). 917–927. 1 indexed citations

Cleary, Yumi, Heidemarie Kletzl, Katja Heinig, et al.. (2023). Estimation of FMO3 Ontogeny by Mechanistic Population Pharmacokinetic Modelling of Risdiplam and Its Impact on Drug–Drug Interactions in Children. Clinical Pharmacokinetics. 62(6). 891–904. 8 indexed citations

Djebli, Nassim, Neil Parrott, Elena Guerini, et al.. (2021). Physiologically-Based Pharmacokinetic Modelling of Entrectinib Parent and Active Metabolite to Support Regulatory Decision-Making. European Journal of Drug Metabolism and Pharmacokinetics. 46(6). 779–791. 10 indexed citations

Hsu, Joy, Elena Guerini, Bogdana Balas, et al.. (2021). Pharmacometric analyses of alectinib to facilitate approval of the optimal dose for the first‐line treatment of anaplastic lymphoma kinase–positive non‐small cell lung cancer. CPT Pharmacometrics & Systems Pharmacology. 10(11). 1357–1370. 8 indexed citations

Djebli, Nassim, et al.. (2021). Population pharmacokinetic analysis of entrectinib in pediatric and adult patients with advanced/metastatic solid tumors: support of new drug application submission. Cancer Chemotherapy and Pharmacology. 88(6). 997–1007. 7 indexed citations

Retout, Sylvie, Christophe Schmitt, Claire Petry, François Mercier, & Nicolas Frey. (2020). Population Pharmacokinetic Analysis and Exploratory Exposure–Bleeding Rate Relationship of Emicizumab in Adult and Pediatric Persons with Hemophilia A. Clinical Pharmacokinetics. 59(12). 1611–1625. 31 indexed citations

Wirth, Stefan, Hongfei Zhang, Winita Hardikar, et al.. (2018). Efficacy and Safety of Peginterferon Alfa‐2a (40KD) in Children With Chronic Hepatitis B: The PEG‐B‐ACTIVE Study. Hepatology. 68(5). 1681–1694. 35 indexed citations

Ueckert, Sebastian, et al.. (2018). Comparison of Model Averaging and Model Selection in Dose Finding Trials Analyzed by Nonlinear Mixed Effect Models. The AAPS Journal. 20(3). 56–56. 24 indexed citations

Retout, Sylvie, et al.. (2017). Item Response Theory as an Efficient Tool to Describe a Heterogeneous Clinical Rating Scale in De Novo Idiopathic Parkinson’s Disease Patients. Pharmaceutical Research. 34(10). 2109–2118. 35 indexed citations

10.

Gibiansky, Leonid, et al.. (2014). Methods to detect non-compliance and reduce its impact on population PK parameter estimates. Journal of Pharmacokinetics and Pharmacodynamics. 41(3). 279–289. 7 indexed citations

11.

Kjellsson, Maria C., Valérie Cosson, Norman A. Mazer, Nicolas Frey, & Mats O. Karlsson. (2013). A Model‐Based Approach to Predict Longitudinal HbA1c, Using Early Phase Glucose Data From Type 2 Diabetes Mellitus Patients After Anti‐Diabetic Treatment. The Journal of Clinical Pharmacology. 53(6). 589–600. 18 indexed citations

12.

Retout, Sylvie, et al.. (2013). Prediction of Shrinkage of Individual Parameters Using the Bayesian Information Matrix in Non-Linear Mixed Effect Models with Evaluation in Pharmacokinetics. Pharmaceutical Research. 30(9). 2355–2367. 22 indexed citations

13.

Levi, Micha, Susan Grange, & Nicolas Frey. (2012). Exposure‐Exposure Relationship of Tocilizumab, an Anti–IL‐6 Receptor Monoclonal Antibody, in a Large Population of Patients With Rheumatoid Arthritis. The Journal of Clinical Pharmacology. 53(2). 151–159. 38 indexed citations

14.

Karlsson, Mats O., et al.. (2011). Identification of the Mechanism of Action of a Glucokinase Activator From Oral Glucose Tolerance Test Data in Type 2 Diabetic Patients Based on an Integrated Glucose‐Insulin Model. The Journal of Clinical Pharmacology. 52(12). 1861–1871. 20 indexed citations

15.

Frey, Nicolas, Susan Grange, & Thasia Woodworth. (2010). Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis. The Journal of Clinical Pharmacology. 50(7). 754–766. 89 indexed citations

16.

Silber, Hanna E., Nicolas Frey, & Mats O. Karlsson. (2009). An Integrated Glucose‐Insulin Model to Describe Oral Glucose Tolerance Test Data in Healthy Volunteers. The Journal of Clinical Pharmacology. 50(3). 246–256. 37 indexed citations

17.

Silber, Hanna E., et al.. (2009). An Integrated Model for the Glucose‐Insulin System. Basic & Clinical Pharmacology & Toxicology. 106(3). 189–194. 26 indexed citations

18.

Silber, Hanna E., Nicolas Frey, Ronald Gieschke, et al.. (2007). An Integrated Glucose‐Insulin Model to Describe Oral Glucose Tolerance Test Data in Type 2 Diabetics. The Journal of Clinical Pharmacology. 47(10). 1244–1255. 61 indexed citations

19.

Lemenuel‐Diot, Annabelle, Christian Laveille, Nicolas Frey, Roeline Jochemsen, & Alain Mallet. (2006). Mixture Modeling for the Detection of Subpopulations in a Pharmacokinetic/Pharmacodynamic analysis. Journal of Pharmacokinetics and Pharmacodynamics. 34(2). 157–181. 6 indexed citations

20.

Frey, Nicolas, Sylvie Nessler, Sonia Fieulaine, et al.. (2003). The HPr(Ser) kinase ofStreptococcus salivarius: a hexameric bifunctional enzyme controlled by glycolytic intermediates and inorganic phosphate. FEMS Microbiology Letters. 224(1). 67–72. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact